Middlemen jittery as Amazon's creepers move toward pharmaceuticals

One interesting corollary of Amazon’s recent acquisition of Whole Foods was the effect on pharmacies, which shed about $10 billion in share price value, according to UBS.

Stocks in drug wholesalers, distributors and pharmacy benefits managers also ebbed on the news, as investors weighed the likely extent of the online giant’s designs on this market.

In one  story, CNBC claimed the diversified retailer holds a meeting every year to weigh up entering the pharmaceuticals market.